MORNINGSIDE PHARMACEUTICALS LIMITED

Active Northampton

Manufacture of pharmaceutical preparations

74 employees website.com
Life sciences and medical technology Manufacture of pharmaceutical preparationsManufacture of medical and dental instruments and supplies +1
M

MORNINGSIDE PHARMACEUTICALS LIMITED

Manufacture of pharmaceutical preparations

Founded 18 Dec 1991 Active Northampton, England 74 employees website.com
Life sciences and medical technology Manufacture of pharmaceutical preparationsManufacture of medical and dental instruments and suppliesWholesale of pharmaceutical goods
Accounts Submitted 4 Jul 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 10 Mar 2026 Next due 21 Mar 2027 10 months remaining
Net assets £37M £10M 2024 year on year
Total assets £51M £2M 2024 year on year
Total Liabilities £13M £8M 2024 year on year
Charges 4
1 outstanding 3 satisfied

Contact & Details

Contact

Registered Address

Nene House 4 Rushmills Northampton NN4 7YB England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for MORNINGSIDE PHARMACEUTICALS LIMITED (02672877), an active life sciences and medical technology company based in Northampton, England. Incorporated 18 Dec 1991. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£1.36M

Decreased by £4.34M (-76%)

Net Assets

£37.23M

Increased by £9.50M (+34%)

Total Liabilities

£13.45M

Decreased by £7.54M (-36%)

Turnover

£84.02M

Increased by £4.59M (+6%)

Employees

74

Decreased by 19 (-20%)

Debt Ratio

27%

Decreased by 16 (-37%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Clifford Roy FungDirectorBritishEngland611 Dec 2021Active

Shareholders

Shareholders (1)

Aspire Bidco Limited
100.0%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased
Ceased

Randalsun Capital Limited

Ceased 30 Sept 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding 3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Mar 2026Confirmation StatementConfirmation statement made on 7 Mar 2026 with no updates
31 Oct 2025OfficersTermination of Timothy James Brady as director on 31 Oct 2025
31 Oct 2025OfficersTermination of Clifford Roy Fung as director on 31 Oct 2025
4 Jul 2025AccountsAnnual accounts made up to 31 Dec 2024
11 Mar 2025Confirmation StatementConfirmation statement made on 7 Mar 2025 with no updates
10 Mar 2026 Confirmation Statement

Confirmation statement made on 7 Mar 2026 with no updates

31 Oct 2025 Officers

Termination of Timothy James Brady as director on 31 Oct 2025

31 Oct 2025 Officers

Termination of Clifford Roy Fung as director on 31 Oct 2025

4 Jul 2025 Accounts

Annual accounts made up to 31 Dec 2024

11 Mar 2025 Confirmation Statement

Confirmation statement made on 7 Mar 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 7 Mar 2026 with no updates

2 months ago on 10 Mar 2026

Termination of Timothy James Brady as director on 31 Oct 2025

6 months ago on 31 Oct 2025

Termination of Clifford Roy Fung as director on 31 Oct 2025

6 months ago on 31 Oct 2025

Annual accounts made up to 31 Dec 2024

10 months ago on 4 Jul 2025

Confirmation statement made on 7 Mar 2025 with no updates

1 years ago on 11 Mar 2025